Article

Fundraiser this weekend to help a sick dog

Author(s):

Melissa Weber

After my post last week about the first drug approved to treat cancer in dogs, I heard about a bulldog named Cash who's undergoing chemotherapy. For anyone living in the Dallas area, there's a fundraiser this Saturday at Urban Dog Coffee to raise money for her treatment. It also appears Cash has her very own blog. I don't know about you, but I'm definitely a sucker for a cute dog.

Related Videos
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Related Content
Illustration of cells.
March 7th 2025

177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset

Spencer Feldman
177Lu-edotreotide shows potential to extend progression-free survival in patients with grade 1 or 2 somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of woman with brown hair.
March 7th 2025

Challenging Cancer Stereotypes While Living with Follicular Lymphoma

Karen Cohn
Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied experiences of patients with cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of blood cells.
March 7th 2025

Calquence Combo May Improve Outcomes in Chronic Lymphocytic Leukemia

Spencer Feldman
Calquence plus Venclexta with or without Gazyva significantly improved progression-free survival in patients with untreated CLL.
Illustration of lung.
March 6th 2025

Presurgical Opdivo Plus Yervoy Has Potential Clinical Benefit in NSCLC

Alex Biese
Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical benefits versus chemotherapy.